The Antisera market in Estonia exhibited fluctuations over the past decade, culminating in a market size of 97.831 million USD in 2023. After a consistent growth trend from 2013 to 2019, the market experienced a notable dip in 2020. However, it rebounded strongly in 2021. Recent years show moderate volatility, with the market stabilizing over 2022 and 2023. The compound annual growth rate (CAGR) over the last five years was approximately 2.64%, indicating modest growth.

Future trends to watch for:

Advancements in biotechnology and increased demand for personalized medicine may influence market dynamics.
Potential challenges include regulatory changes and supply chain disruptions affecting production and distribution.
Market expansion opportunities in rare disease treatment may drive growth.